
For decades, the United States led the charge in the pursuit of brain-computer interface technology, betting big on bold, high-risk breakthroughs that promised to revolutionise medicine and human-machine integration.
In the end, it is China crossing the finish line first.
Advertisement
After decades of this technology being stuck in clinical trials globally, this feat makes their Neural Electronic Opportunity (Neo) implant the first invasive device in the world to be available outside trials.
Advertisement
The development of BCI has been defined by a difficult trade-off: a non-invasive approach that sacrifices precision or an invasive approach that sacrifices safety.

Don't Miss:
-
Vance and Rubio emerge as early contenders to inherit Trump’s Republican Party
-
India raises diesel, petrol prices for third time in 8 days, amid tense US-Iran ceasefire
-
Is China building the world’s largest naval support ship?
-
Three Mexican Meth Cooks Arrested at Drug Lab in Nigeria
-
New Zealand to invest almost US$1 billion in drones, ships to protect maritime security

Trump, Xi, and a Defining Moment for the World
David Lapp on the Case Against Forcing Residential Consumers to Pay for Skyrocketing Data Center Costs
Elizabeth Burch on the Dark Side of the Tort Bar